[1]何 丽.三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂效果对比[J].医学信息,2022,35(11):150-153.[doi:10.3969/j.issn.1006-1959.2022.11.040]
　HE Li.Comparison of Three Statins in the Treatment of Elderly Patients with Atherosclerotic Acute Cerebral Infarction Combined with Hyperlipidemia[J].Medical Information,2022,35(11):150-153.[doi:10.3969/j.issn.1006-1959.2022.11.040]
点击复制

三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂效果对比()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年11期
页码:
150-153
栏目:
论著
出版日期:
2022-06-01

文章信息/Info

Title:
Comparison of Three Statins in the Treatment of Elderly Patients with Atherosclerotic Acute Cerebral Infarction Combined with Hyperlipidemia
文章编号:
1006-1959（2022）11-0150-04
作者:
何 丽
（天津市职业病防治院体检科，天津 300011）
Author(s):
HE Li
(Department of Physical Examination,Tianjin Occupational Disease Precaution and Therapeutic Hospital,Tianjin 300011,China)
关键词:
动脉粥样硬化性急性脑梗死; 高血脂; 辛伐他汀; 阿托伐他汀; 瑞舒伐他汀
Keywords:
Atherosclerotic acute cerebral infarction; Hyperlipidemia; Simvastatin; Atorvastatin; Rosuvastatin
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.11.040
文献标志码:
A
摘要:
目的 观察三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死（AACI）合并高血脂的临床效果。方法 选取2019年1月-2020年12月天津市职业病防治院收治的65例老年AACI合并高血脂患者，采用随机数字表法分为辛伐他汀组（21例）、阿托伐他汀组（22例）、瑞舒伐他汀组（22例）；分别给予辛伐他汀、阿托伐他汀、瑞舒伐他汀治疗，比较三组血脂水平[酰甘油（TG）、总胆固醇（TC）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）]、炎性因子[C反应蛋白（CRP）、白介素-6（IL-6）、肿瘤坏死因子-α（TNF-α）]、神经功能缺损评分（NIHSS）、肝功能[谷丙转氨酶（ALT）、谷草转氨酶（AST）]及不良反应。结果 瑞舒伐他汀组TG、TC、LDL-C低于辛伐他汀组与阿托伐他汀组，HDL-C高于辛伐他汀组与阿托伐他汀组（P＜0.05）；三组CRP、IL-6、TNF-α水平及NIHSS评分均低于治疗前，且瑞舒伐他汀组低于辛伐他汀组与阿托伐他汀组（P＜0.05）；辛伐他汀组与阿托伐他汀组ALT、AST水平高于治疗前，且高于瑞舒伐他汀组（P＜0.05）；瑞舒伐他汀组治疗前后ALT、AST水平比较，差异无统计学意义（P＞0.05）；三组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 辛伐他汀、阿托伐他汀与瑞舒伐他汀三种他汀类药物均具有良好的降脂效果，可下调老年AACI合并高血脂患者的炎性反应，改善其神经功能，且不良反应少，其中瑞舒伐他汀的治疗效果及安全性最为理想。
Abstract:
Objective To observe the clinical effect of three statins in the treatment of elderly patients with atherosclerotic acute cerebral infarction (AACI) combined with hyperlipidemia.Methods A total of 65 elderly AACI patients with hyperlipidemia admitted to Tianjin Occupational Disease Precaution and Therapeutic Hospital from January 2019 to December 2020 were selected and randomly divided into simvastatin group (21 cases), atorvastatin group (22 cases) and rosuvastatin group (22 cases). Simvastatin, atorvastatin and rosuvastatin were given respectively. The blood lipid levels [triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C)], inflammatory factors [C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)], neurological deficit score (NIHSS), liver function [alanine aminotransferase (ALT), aspartate aminotransferase (AST)] and adverse reactions were compared among the three groups.Results The levels of TG, TC and LDL-C in rosuvastatin group were lower than those in simvastatin group and atorvastatin group, and The level of HDL-C was higher than that in simvastatin group and atorvastatin group (P＜0.05). The levels of CRP, IL-6, TNF-α and NIHSS scores in the three groups were lower than those before treatment, and those in the rosuvastatin group was lower than those in the simvastatin group and the atorvastatin group (P＜0.05). The levels of ALT and AST in simvastatin group and atorvastatin group were higher than those before treatment, and higher than those in rosuvastatin group (P＜0.05). There was no significant difference in ALT and AST levels before and after treatment in rosuvastatin group (P＞0.05). There was no significant difference in the incidence of adverse reactions among the three groups (P＞0.05).Conclusion Simvastatin, atorvastatin and rosuvastatin have good lipid-lowering effects, which can reduce the inflammatory response of elderly AACI patients with hyperlipidemia, improve their neurological function, and have few adverse reactions. Among them, rosuvastatin has the best therapeutic effect and safety.

参考文献/References:

[1]刘永刚,姜凤,姜尧佳.瑞舒他汀钙药物干预对急性脑梗死患者疗效及血清内脂素水平的影响[J].黑龙江医药科学,2021,44(5):7-9.[2]文洪波,杨军,邹荣成,等.阿托伐他汀与匹伐他汀对急性大动脉粥样硬化型脑梗死患者颈动脉斑块、血脂水平及安全性的影响[J].广西医科大学学报,2021,38(9):1765-1769.[3]宋晓英,冯丽.辛伐他汀对急性脑梗死患者血浆中PTEN、HIF-1α表达和预后的影响[J].延安大学学报(医学科学版),2021,19(3):32-35.[4]Deguchi I,Horiuchi Y,Hayashi T,et al.Effects of Rosuvastatin on Serum Lipids and Arteriosclerosis in Dyslipidemic Patients with Cerebral Infarction[J].J Stroke Cerebrovasc Dis,2014,23(8):2007-2011.[5]刘建青,乔晋,王宏.阿托伐他汀、辛伐他汀和瑞舒伐他汀对高脂血症的疗效比较[J].药物评价研究,2017,40(10):1457-1459.[6]彭斌,吴波.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.[7]李土明,吴滢,钟萍,等.脑小血管病总体负担与急性大动脉粥样硬化性脑梗死认知功能障碍的相关性[J].中国实用神经疾病杂志,2021,24(15):1306-1311.[8]高洪辉.不同他汀类药物对急性脑梗死并高脂血症患者血脂指标和炎性因子影响的比较研究[J].临床合理用药杂志,2020,13(12):40-41.[9]常喜梅.不同他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂患者的效果对比研究[J].中西医结合心血管病电子杂志,2020,8(9):36,39.[10]刘宇兰,余生艳,高艳.三种降脂药物对老年急性脑梗死合并高血脂患者治疗效果及血脂水平的影响分析[J].贵州医药,2020,44(1):57-59.[11]姚丽娜,李美杰,王艳珍,等.瑞舒伐他汀和阿托伐他汀对急性脑梗死病人血脂与颈动脉粥样硬化斑块的影响[J].中西医结合心脑血管病杂志,2018,16(24):3714-3717.[12]刘宜平.高血脂合并动脉粥样硬化性脑梗死的治疗观察[J].中国继续医学教育,2019,11(21):122-124.[13]纪利利,李美杰,姚丽娜,等.他汀类药物治疗急性脑梗死对患者颈动脉粥样硬化斑块及炎症反应的影响[J].现代中西医结合杂志,2018,27(22):2491-2494.[14]Zhang JY,Liu B,Wang YN,et al.Effect of Rosuvastatin on OX40L and PPAR-γ Expression in Human Umbilical Vein Endothelial Cells and Atherosclerotic Cerebral Infarction Patients[J].J Mol Neurosci,2014,52(2):261-268.[15]韩石蕊,赵永旗,程洪兵,等.瑞舒伐他汀钙与阿托伐他汀钙对动脉粥样硬化急性脑梗死合并高血脂的疗效比较[J].药物评价研究,2018,41(1):122-125.[16]周华勇,杨旭,杜鑫,等.瑞舒伐他汀与阿托伐他汀强化降脂治疗急性脑梗死临床效果比较[J].实用医院临床杂志,2019,16(6):136-138.[17]钱坤,步文广,王金虎,等.不同剂量阿托伐他汀对急性脑梗死患者降脂效果及预后的影响[J].实用临床医药杂志,2016,20(13):149-150.[18]李娜.阿托伐他汀对急性脑梗死患者脑神经功能及血清sICAM-1、TNF-α表达的影响[J].黑龙江医药科学,2021,44(4):105-106.[19]杨永平.不同剂量瑞舒伐他汀对急性脑梗死患者神经功能及血清hs-CRP的影响[J].现代诊断与治疗,2021,32(18):2894-2896.[20]张云书.三种降脂药物对老年急性脑梗死合并高血脂患者治疗效果及血脂水平的影响分析[J].中国循证心血管医学杂志,2016,8(2):213-216.[21]万芳超,谭莉,李晓辉,等.他汀类药物对ICAM-1、ET-1、MMP-9的影响及其与阿替普酶溶栓后出血转化的相关性[J].脑与神经疾病杂志,2020,28(8):481-485.[22]陈霓红,周俊山,施洪超,等.早期他汀治疗对急性脑梗死静脉溶栓患者血浆基质金属蛋白酶-9水平及短期预后的影响[J].临床神经病学杂志,2016,29(1):18-22.[23]张秋霞.瑞舒伐他汀、辛伐他汀及阿托伐他汀应用于老年动脉粥样硬化性急性脑梗死效果差异分析[J].齐齐哈尔医学院学报,2019,40(8):994-995.[24]Yan L,Zhu T.Effects of rosuvastatin on neuronal apoptosis in cerebral ischemic stroke rats via Sirt1/NF-kappa B signaling pathway[J].Eur Rev Med Pharmacol Sci,2019,23(12):5449-5455.[25]吉凤,徐小林.三种他汀类药物治疗老年动脉粥样硬化性急性脑梗死合并高血脂效果对比观察[J].山东医药,2014,54(28):50-52.

更新日期/Last Update: 1900-01-01